Non-Invasive Oral Brush Biopsy with AI-enabled Tissue Analysis
OralCDx allows you to painlessly test any white or red spot in the mouth to rule out the possibility that precancerous cells are present.
If dysplasia is found, the cells can typically be removed in order to stop the progression of oral cancer.
Oral cancer is rising in low risk groups.
Oral cancer kills about as many Americans as melanoma and twice as many as cervical cancer.
Oral cancer is rising in women, young people and non-smokers.
At least 25% of oral cancer victims have no known risk factors.
Finding oral cancer is too late
By the time a lesion appears suspicious for cancer, it is generally dangerous, often life-threatening
Easy-to-perform
In-office procedure - no need to reschedule patient
Painless – well-accepted by patients
Transepithelial Sampling
Uniquely designed sampling brush allows for the collection of cells from the full thickness of the oral epithelium.
The disaggregated specimen requires proprietary imaging and neural network algorithm to sift through the dense tissue to find potential abnormality.
The brush biopsy requires no anesthesia, causes no pain and minimal or no bleeding.
Reliable – Clinically shown to be at least as sensitive as a scalpel in ruling our precancer or cancer.
Advanced AI-Enabled
Tissue Analysis
An advanced neural network performs tests on every cell to detect hidden abnormalities.
The proprietary technology has been adapted for optimal detection of cellular abnormalities that are unique to oral brush biopsy samples.
The system identifies the most suspicious cells and cell clusters and highlights them for evaluation and diagnosis by specially-trained pathologists.